These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 5759058)

  • 1. A light and electron microscopic study of arteries and other tissues from dogs subjected to chronic fibrinolytic inhibition with AMCHA.
    Steenblock DA; Celander DR
    Vasc Surg; 1968 Sep; 2(3):149-56. PubMed ID: 5759058
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of trans-4-aminomethylcyclohexane carboxylic acid as an antifibrinolytic agent on arterial wall and experimental atherosclerotic lesions in rabbits.
    Kato N; Morimatsu M; Tanaka K; Horie A
    Thromb Diath Haemorrh; 1970 Oct; 24(1):85-99. PubMed ID: 5483976
    [No Abstract]   [Full Text] [Related]  

  • 3. Tranexamic acid and fibrinolytic activity of the vessel wall.
    Astedt B; Liedholm P
    Experientia; 1974 Jul; 30(7):776-7. PubMed ID: 4847668
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of an inhibitor of fibrinolysis upon the intravascular clearance of fibrin monomer in dogs.
    Pratt HW; Celander DR
    J Am Osteopath Assoc; 1970 Jun; 69(10):1049-50. PubMed ID: 5201432
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative studies on the antifibrinolytic effect (in vitro and in vivo) of t-AMCHA, phenyl-t-AMCHA, trasylol].
    Moriguchi S
    Nihon Seirigaku Zasshi; 1971; 33(6):355-63. PubMed ID: 5315192
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the mechanism of action of synthetic antifibrinolytics. A comparison with the action of derivatives of benzamidine on the fibrinolytic process.
    Landmann H
    Thromb Diath Haemorrh; 1973 May; 29(2):253-75. PubMed ID: 4271586
    [No Abstract]   [Full Text] [Related]  

  • 7. [Metabolism of fibrinogen following administration of brain phospholipids in combination with an antifibrinolytic agent (AMCHA)].
    Cultrera G; Lampugnani P
    Arzneimittelforschung; 1973 Mar; 23(3):445-7. PubMed ID: 4740135
    [No Abstract]   [Full Text] [Related]  

  • 8. [Animal experiment methods for the testing of fibrinolytic and antifibrinolytic agents].
    Klöcking HP; Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 92(1):84-9. PubMed ID: 4189378
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention of vessel wall damage in experimental irradiation.
    Smit Sibinga CT
    Bibl Anat; 1973; 12():242-8. PubMed ID: 4275205
    [No Abstract]   [Full Text] [Related]  

  • 10. Fibrinogen turnover and drugs acting on fibrinolysis.
    De Nicola P
    Acta Univ Carol Med Monogr; 1972; 52():25-31. PubMed ID: 4544612
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of in vivo effects on components of the canine fibrinolytic enzyme system of AMCHA fed at varying dose levels.
    Celander E; Celander DR
    Thromb Diath Haemorrh; 1968 Dec; 20(3):547-82. PubMed ID: 5710471
    [No Abstract]   [Full Text] [Related]  

  • 12. Metabolism and distribution of fibrinogen. I. Fibrinogen turnover in physiological conditions in humans.
    Collen D; Tytgat GN; Claeys H; Piessens R
    Br J Haematol; 1972 Jun; 22(6):681-700. PubMed ID: 5064500
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemical control of hyperfibrinolytic states by synthetic inhibitors of fibrinolytic enzymes.
    Markwardt F; Klöcking HP
    Biomed Biochim Acta; 1983; 42(6):725-30. PubMed ID: 6605748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative assessment of fibrinolysis on isolated glomeruli.
    Sraer JD; Boelaert J; Mimoune O; Morel-Maroger L; Hornych H
    Kidney Int; 1973 Nov; 4(5):350-2. PubMed ID: 4762582
    [No Abstract]   [Full Text] [Related]  

  • 15. [On the effect of a new synthetic inhibitor of the fibrinolytic system].
    Fischer M; Pavlu C
    Arzneimittelforschung; 1966 May; 16(5):671-3. PubMed ID: 6014440
    [No Abstract]   [Full Text] [Related]  

  • 16. Experimental studies on the production of pulmonary infarction. IV. Effects of UK, heparin, t-AMCHA or ellagic acid.
    Hasegawa H; Watanabe N; Kakizaki H; Murata H
    Jpn Heart J; 1973 Jul; 14(4):335-49. PubMed ID: 4542948
    [No Abstract]   [Full Text] [Related]  

  • 17. [The determination of fibrinolysis activators].
    Astedt B; Pandolfi M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(1):132-7. PubMed ID: 4134262
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of trans-AMCHA (trans-aminomethylcyclohexanecarboxylic acid) on fibrinolytic activity].
    Leube G; Kuehn JJ
    Med Welt; 1969 Aug; 34():1846-50. PubMed ID: 4185877
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthetic inhibitors of fibrinolysis: in vitro and in vivo mode of action.
    Okamoto S; Oshiba S; Mihara H; Okamoto U
    Ann N Y Acad Sci; 1968 Jun; 146(2):414-29. PubMed ID: 5254270
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of fibrinolysis and coagulation on haemostatic plug formation. An experimental study in rabbits.
    Bergqvist D; Arfors KE
    Thromb Res; 1974 Feb; 4(2):345-60. PubMed ID: 4831008
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.